Set Your Location to See Relevant Information

Setting your location helps us to show you nearby providers and locations based on your healthcare needs.

Jane B. Borkowski, MD


Medical Oncology

Conditions Treated

head and neck cancer, hematologic cancer, breast cancer, endometrial cancer, leukemia, lung cancer, lymphoma, and ovarian cancer

Procedures Performed

medical oncology treatment of head and neck cancer, medical oncology treatment of hematologic cancer, medical oncology treatment of breast cancer, medical oncology treatment of endometrial cancer, medical oncology treatment of leukemia, medical oncology treatment of lung cancer, medical oncology treatment of lymphoma, and medical oncology treatment of ovarian cancer

Contact Information

  • Office: 425-441-2600
  • Fax: 425-441-2700







Board Certification

Board Certified in Medical Oncology
Board Certified in Internal Medicine


Dr. Jane Borkowski is a board certified medical oncologist with more than 15 years of experience caring for patients with cancer. She is also a Clinical Assistant Professor of Medicine at the University of Washington.
Dr. Borkowski sees patients exclusively at the Halvorson Cancer Center.

Clinical Expertise

Breast cancer
Gynecologic cancers
Lung cancer
Head and neck cancers

Philosophy of Care

I value caring for you in a collaborative manner to present information while offering guidance and expertise to make treatment decisions.

Medical School

Johns Hopkins University School of Medicine | Baltimore, MD


University of Washington School of Medicine | Seattle, WA


University of Washington (medical oncology) | Seattle, WA


University of Washington School of Medicine | Seattle, WA

Personal Information

When I was a Peace Corps volunteer in Ecuador, I worked with a group of doctors whose compassion and dedication motivated me to study medicine. I find that I connect well with patients facing severe illness and can help give them support through a difficult time.
In my lifetime, I would like to see medicine grow toward more patient-specific, tailored diagnostic and therapeutic treatments to improve survival and lower toxicity.